ETFs positioned on Haisco Pharmaceutical Group Co., Ltd.

Name Weight AuM 1st Jan change Investor Rating
0.00% 113 M€ +7.83% -
0.00% 32 M€ +4.78% -
Logo Haisco Pharmaceutical Group Co., Ltd.
Haisco Pharmaceutical Group Co.,Ltd., formerly Xizang Haisco Pharmaceutical Group Co., Ltd., is a China-based company principally engaged in the research, development, manufacture and sale of new drugs and high-end medical instrument. The Company’s main products are categorized into small volume injections, big volume injections, freeze-dried powder injections and others, which include polyene phosphatidylcholine injections, lipid solubility vitamins injection series, doradiazine methanesulfonate injections, nalmefene hydrochloride injections, fluprofen tromethamine tablets and cefoperazone sodium tazobactam sodium for injections, among others. The Company distributes its products in domestic market.
Employees
5,448
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
27.76CNY
Average target price
36.19CNY
Spread / Average Target
+30.37%
Consensus
  1. Stock Market
  2. Equities
  3. 002653 Stock
  4. ETFs Haisco Pharmaceutical Group Co., Ltd.